Welcome to the International Oncology Cancer Institute (IOCI) in Indore, a distinguished beacon of excellence in the domain of oncology care. Acknowledging the imperative for a comprehensive cancer institute furnished with cutting-edge technologies and premier medical care, we proudly present a new comprehensive cancer care hospital in Indore. With a decade of devoted service, our Indore hospital, nestled within CHL Hospital 114, has emerged as a prominent cancer care institution, offering the region's only comprehensive, highly equipped, and advanced cancer care services.

Spanning over 15 years, our unwavering commitment to delivering the highest quality cancer care is propelled by the latest strides in diagnostic and therapeutic research. Our primary mission revolves around empowering you to stand resolute in your fight against cancer.

At IOCI India (International Oncology Cancer Institute), our focal point is centered on you—the patient. Our team of experienced oncologists is dedicated to crafting personalized treatment plans tailored to address a diverse range of cancer types. Through seamless collaboration within a multidisciplinary framework, we provide comprehensive care that includes chemotherapy, targeted therapy, and immunotherapy—each guided by genetic insights. With a network encompassing seven state-of-the-art hospitals, our devotion to compassionate care and groundbreaking innovation stands unparalleled.

Our facilities boast the latest technologies, including a PET Scan, comprehensive operating theaters, highly equipped diagnostics, dedicated outpatient consultations, and advanced chemotherapy and radiation setups. Notably, we take pride in being the sole host of the PET scan facility in Indore, offering the medical community cutting-edge advancements. This steadfast commitment to medical progress ensures adaptable treatment options and advanced imaging, all while placing your safety at the forefront.

Rest assured, a global team of experts seamlessly blending compassion and expertise is at your service. Operating in unison, we are steadfast in our commitment to delivering transformative cancer care that sets novel benchmarks within the field.